Ontology highlight
ABSTRACT: Objective
Prenatal diagnoses of microdeletion syndromes without ultrasound findings in the first and second trimester are always difficult. The objective of this study is to report the prenatal ultrasound findings in four foetuses diagnosed with 17q21.31 microdeletions (Koolen-de Vries syndrome) using chromosomal microarrays (CMA).Patients and methods
We present four foetuses with 17q21.31 microdeletion. All showed CNS anomalies in the third trimester, three had ventriculomegaly, and one hypogenesis of corpus callosum at 31 weeks of pregnancy.Results
Array-SNPs and CGH-array were performed on uncultured amniocytes and peripheral blood revealing a 17q21.31 microdeletion.Conclusions
Prenatal CNS anomalies (mainly ventriculomegaly) at third trimester, in spite of isolate, should be considered a prenatal ultrasound marker of this syndrome. This kind of malformations raise the possibility of an underlying genetic conditions including 17q21.31 microdeletion; thus, CMA should be taken into consideration when offering prenatal genetic counselling.
SUBMITTER: Garcia-Santiago FA
PROVIDER: S-EPMC8172212 | biostudies-literature | 2021 May
REPOSITORIES: biostudies-literature
García-Santiago Fe Amalia FA Martínez-Payo Cristina C Mansilla Elena E Santos-Simarro Fernando F Ruiz de Azua Ballesteros Miguel M Mori María Ángeles MÁ Antolín Alvarado Eugenia E Nieto Yolanda Y Vallcorba Isabel I Tenorio Jair J Nevado Julián J Lapunzina Pablo P
Molecular genetics & genomic medicine 20210318 5
<h4>Objective</h4>Prenatal diagnoses of microdeletion syndromes without ultrasound findings in the first and second trimester are always difficult. The objective of this study is to report the prenatal ultrasound findings in four foetuses diagnosed with 17q21.31 microdeletions (Koolen-de Vries syndrome) using chromosomal microarrays (CMA).<h4>Patients and methods</h4>We present four foetuses with 17q21.31 microdeletion. All showed CNS anomalies in the third trimester, three had ventriculomegaly, ...[more]